Renzapride

From Wikipedia, the free encyclopedia

Chemical structure of Renzapride
Chemical structure of Renzapride

Renzapride is a full serotonin 5-HT4 receptor agonist, partial serotonin 5-HT3 receptor antagonist.

[edit] Clinical Uses

Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It is also potentially effective for irritable bowel syndrome with alternating stool pattern (IBS-A). It is being developed by Alizyme of the UK.

Pills  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../r/e/n/Renzapride.html"